Can CT Enteroclysis Predict the Outcome of Crohn's Disease
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Indiana University.
Recruitment status was Active, not recruiting
Information provided by:
First received: December 11, 2007
Last updated: NA
Last verified: December 2007
History: No changes posted
Specific CT Enteroclysis findings with or without other clinical and laboratory variables, can identify Crohn's disease patients who will response to medical therapy versus those who will either fail and require surgery or have uncontrolled disease.
||Observational Model: Cohort
Time Perspective: Retrospective
||Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
CTE with CD
Crohn's disease patients who underwent a CT enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease.
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Crohn's disease patients that have had a CT Enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease will be eligible. Subjects who were later diagnosied with bowel malignancy and subjects with a period of follow-up of less than 1 year(without surgery) will be excluded.
- Crohn's disease with CT Enteroclysis during symptomatic treatment
- Crohn's disease subjects who have had a follow-up less than 1 year, without surgery
- Crohn's disease subjects that were later diagnosed with a bowel malignancy
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00572780
|Indianapolis, Indiana, United States, 46202 |
||Michael V. Chiorean, M.D.
No publications provided
||Michael V. Chiorean M.D., Indiana University
History of Changes
|Other Study ID Numbers:
|Study First Received:
||December 11, 2007
||December 11, 2007
||United States: Institutional Review Board
Keywords provided by Indiana University:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on April 16, 2015
Digestive System Diseases
Inflammatory Bowel Diseases